CAMV
LLY icon

Concord Asset Management (Virginia)’s Eli Lilly LLY Stock Holding History

Concord Asset Management (Virginia)’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.83M Buy
3,192
+239
+8% +$244K 0.59% 42
2026
Q1 		$2.72M Sell
2,953
-249
-8% -$252K 0.46% 57
2025
Q4 		$3.44M Sell
3,202
-46
-1% -$44K 0.6% 38
2025
Q3 		$2.48M Sell
3,248
-404
-11% -$301K 0.45% 57
2025
Q2 		$2.85M Buy
3,652
+614
+20% +$477K 0.43% 54
2025
Q1 		$2.52M Sell
3,038
-1,879
-38% -$1.56M 0.56% 46
2024
Q4 		$3.8M Buy
4,917
+377
+8% +$312K 0.83% 31
2024
Q3 		$4.02M Buy
4,540
+485
+12% +$436K 0.91% 34
2024
Q2 		$3.67M Buy
4,055
+597
+17% +$478K 0.91% 28
2024
Q1 		$2.69M Buy
3,458
+590
+21% +$420K 0.71% 39
2023
Q4 		$1.67M Buy
2,868
+1,228
+75% +$717K 0.49% 45
2023
Q3 		$881K Buy
1,640
+258
+19% +$133K 0.3% 57
2023
Q2 		$648K Buy
1,382
+174
+14% +$73K 0.23% 56
2023
Q1 		$415K Buy
+1,208
New +$407K 0.17% 66

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Concord Asset Management (Virginia)'s LLY Position: Q2 2026 in Review

Concord Asset Management (Virginia) increased its Eli Lilly (LLY) stake by 8.1% in Q2 2026, buying an estimated $244K and bringing the position to 3,192 shares worth $3.83M. The position accounts for 0.59% of the portfolio, ranked #42.

Concord Asset Management (Virginia) first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. The position peaked at $4.02M in Q3 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Concord Asset Management (Virginia) held 3,192 shares of Eli Lilly worth $3.83M as of Q2 2026.
  • Concord Asset Management (Virginia) bought 239 Eli Lilly shares in Q2 2026, an estimated $244K.
  • Eli Lilly made up 0.59% of Concord Asset Management (Virginia)'s portfolio in Q2 2026, its #42 holding.
  • Concord Asset Management (Virginia) first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • Concord Asset Management (Virginia)'s Eli Lilly position peaked at $4.02M in Q3 2024.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Concord Asset Management (Virginia)'s 13F filing for Q2 2026, filed 27 Jul 2026.